The FDA should NOT have granted approval for roll-out in the 6 month to 4 yr old children cohort
"Dr Clare Craig explains why the FDA should NOT have granted approval for roll-out in the 6 month to 4 yr old children cohort This trial should have been deemed null and void. The regulators are failing to do their job."
Comments